PAB 0.00% 0.7¢ patrys limited

ONXY trial

  1. 1,235 Posts.
    lightbulb Created with Sketch. 25
    According to the announcement on the 28th May, this trial will begin by years end.........????

    Patrys’ next clinical trial will be using a second generation proteosome
    inhibitor (Kyprolis (Carfilzomib)) in combination with PAT-SM6. The planning for this trial and the
    manufacturing of the required PAT-SM6 is currently underway and we expect to commence the trial
    before the end of 2014.”
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $9.941K 1.420M

Buyers (Bids)

No. Vol. Price($)
2 51753 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1638632 8
View Market Depth
Last trade - 14.08pm 28/06/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.